Ausgabe 4/2000
Inhalt (9 Artikel)
The Importance of Achieving Additional Drug Benefits at a Reasonable Cost
Nick Freemantle, James Mason
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
Anthony O’Hagan, John W. Stevens, Jacques Montmartin
Potential Savings in the Cost of Caring for Alzheimer’s Disease
A. Brett Hauber, Ari Gnanasakthy, Edward H. Snyder, Mohan V. Bala, Anke Richter, Josephine A. Mauskopf
Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy
Mark Sculpher, Michael K. Palmer, Anne Heyes
Initial Treatment Choice in Depression
Eric T. Edgell, Timothy R. Hylan, JoLaine R. Draugalis, Stephen Joel Coons
Cost Analysis of the Treatment of Schizophrenia in the UK
Stephen Almond, Owen O’Donnell
Cost Effectiveness of Competing Strategies to Prevent or Treat GORD-Related Dysphagia
Amnon Sonnenberg